Dunlops has changed its name to Henry Schein Animal Health.
David Hinton, Managing Director said: "As we change our name to Henry Schein Animal Health, we also reaffirm our company's strong commitment to offer a comprehensive array of products and services to help animal health practitioners in the United Kingdom operate more efficient and successful practices, and provide the best quality patient care.
"We have a new name, but we have the same strong team, the same values, and the same dedication to providing excellent service to our customers."
Henry Schein Animal Health’s expanded offerings include VetLink and Thrive. VetLink is a new e-commerce web site system that enables veterinary surgeons to access the growing internet sector, allowing you to sell anything from pet prescriptions to accessories online, to be delivered to your customers’ homes by Henry Schein Animal Health. Thrive is a new veterinary business analysis service that integrates with practice management software to use a Key Performance Indicator based approach that provides insight into a your practice and identifies areas where you can enhance your business.
The BSAVA has announced a partnership with the University of Liverpool to develop a national UK disease surveillance network for companion animals.
Originally established in 2008, the Small Animal Veterinary Surveillance Network, SAVSNET, aimed to monitor the disease status of the UK small animal population (mainly dog, cat and rabbit). However, funding for the project came to an end in August 2011. At this point, BSAVA stepped in with support, as it believed that not only would the profession benefit from this source of information, but that it is in fact vital for the successful management of disease in small animals.
BSAVA President Andrew Ash said: "SAVSNET ticks all the boxes for BSAVA. High quality large scale epidemiological research helps us fulfil our obligations as a charity to public good, the information on disease surveillance gives us the information to treat animals better, and the research papers help us inform veterinary policy and education. This is an important scheme for both animal and human health."
Participation by diagnostic labs and practices is voluntary, and all data gained will be made anonymous before being reported. For more information, email savsnet@liverpool.ac.uk.
The London Vet Show was a runaway success this year, with more delegates on day one than visited the entire show in 2010.
Rob Chapman from CloserStill Media, organiser of the event said: "We're still number crunching, but it looks like numbers were up something like 40% on last year."
VetSurgeon.org visited the event and filmed a number of the commercial exhibitors, many of whom said what a good atmosphere there was at the show and how busy it was.
CloserStill has already confirmed that the London Vet Show will again take place in the Grand Hall at London Olympia next year. However, it will be expanding into West Hall for the clinical lectures, so that everyone can have a seat, unlike this year when demand was so high, some had to sit on the floor.
Vetoquinol has announced that the 50g pack size of Ipakitine will shortly be replaced by a 60g pot.
The company says this will provide the convenience of a 30 day supply for a 5kg cat or dog who is on 1g/5kg bodyweight twice a day (one level scoop twice a day).
The 60g pot will be available from the end of December. Also at this time, the existing 150g size pot will be replaced by a 180g pot.
The new packaging is more eye-catching, easier to read and gives more description. A 300g pot will also be available in February 2012. Pricing will be in-line with increase in pack size, so proportionally a 20% increase for 20% more product.
Ipakitine is a phosphate binder formulated specifically for veterinary use. It is designed for both cats and dogs and is available as a tasteless powder formulation for easy administration with food.
Fitzpatrick Referrals scooped two awards at last week's Vet Marketing Awards, held at the London Vet Show.
The practice picked up the Training Initiatives Award, in recognition of its CPD, Internship and Residency programmes, the launch of Fitzpatrick Learning Academy and the commitment of Fitzpatrick Referrals to pushing the boundaries to advance the veterinary profession.
Noel Fitzpatrick was also awarded the 2011 Science prize for his dedication and commitment to moving the profession forward through scientific and technological development, his research, philosophy and practice.
Organised by Grove House Publishing, who produce OvertheCounter magazine,Vet Marketing and Farm Business, the Vet Marketing Awards are designed to award best practice companies and individuals who are driving innovation in branding, communications and product development, in a way that promotes health and wellbeing for the good of practice, customer, and animals in their care.
Commenting on the Training Initiatives Award, the judges said: "The mission of Fitzpatrick Referrals is to deliver 'the best level of surgical, medical and compassionate care for small animals,' and they have certainly achieved this since the opening of their state-of-the-art practice in 2008. To offer their unparalleled level of care means a high level of training for their staff, and for vets and trainees from across the country. The judges were impressed that they offer more residencies, internships and fellowships than any other private practice in Europe, their commitment to CPD and the in-depth nature of their entry."
Presenting Noel Fitzpatrick with his Science Award, host of the awards ceremony, Alan Whibley, publisher of Vet Marketing said: "For the judges, this is was by far the winner in this category. Noel Fitzpatrick advances scientific and technological development in the veterinary profession, based on the moral and ethical obligation to adopt these new techniques responsibly. He pushes the boundaries, through technology, and also his support for his fellow veterinarians, through internships, CPD lectures and key note speeches, such as the one earlier today. He promulgates the moral imperative to ensure that whilst the client is fully aware of every procedure possible, that a pet is a member of the family and should be treated as such."
Norbrook Laboratories has launched NoroQuin, a nutritional glucosamine-based supplement which the company claims will help maintain healthy cartilage and joint fluids in cats, dogs and horses.
The NoroQuin range has six active ingredients including glucosamine, chondroitin sulphate, manganese sulphate, zinc sulphate, absorbic acid and N-Acetyl-D-Glucosamine which combine to maintain glycosaminoglycans (GAGs) levels in joints and, according to Norbrook, ease and reduce the onset of joint damage and cartilage degeneration.
Michelle Jones, Norbrook Brand Manager, said: "Our new NoroQuin range is an exciting new development to our joint-management range.
"NoroQuin offers more ingredients than the competition with 6 active ingredients working together to help improve mobility. The main ingredient, glucosamine stimulates natural repair and prevents cartilage degeneration and thinning while it is widely considered that glucosamine and chondroitin sulphate have anti-inflammatory properties, making Noroquin ideal for assisting with pain management. The addition of manganese sulphate helps stimulate natural cartilage repair."
NoroQuin is available in a range of meat flavoured tablet sizes that have been formulated to treat all dogs from growing puppies to the largest dogs. For cats, the range is available in a tablet form or as a powder which can be added to a cat's food.
NoroQuin for dogs and cats is available to order from wholesalers now.
Bayer Animal Health has announced that it will launch Seresto, a new POM-V collar for cats and dogs that kills fleas and repels and kills ticks for up to eight months, in March.
According to Bayer, Seresto is the first treatment to provide repellency against ticks in both cats and dogs, and represents the fruit of a multidisciplinary effort incorporating the company's research into insecticides, polymers and veterinary parasiticides. The end result is a polymer-based collar that transfers the active ingredients to the lipid layer, from where they are spread by the animal's neutral oils.
Bayer Animal Health group product manager, Caroline Braidwood, said: "Seresto is simple to use on both cats and dogs. And because it is long lasting, it offers pet owners an alternative to those struggling to maintain a monthly routine. Bayer believes in innovation and Seresto is an enhancement to our product portfolio that meets the needs and requirements of pet owners and vets alike in the treatment of ticks and fleas."
Seresto contains two active ingredients - imidacloprid for fast action against fleas and flumethrin, which repels and kills ticks.
Caroline added: "Thanks to Seresto's unique polymer structure the active ingredients are safely locked away in the collar's matrix, and are released directly from the collar surface into the lipid layer of the animal at just the dose needed, ensuring optimal protection is sustained for up to 8 months."
Bayer says that because of its repellent (anti-feeding) effect, Seresto reduces the risk of vector-borne disease transmission - a first for cats. The company also says that because the active ingredients are stored on the inside of the polymer, it doesn't matter if the pet is shampooed and the lipid layer stripped off - the active ingredients are quickly replenished by the collar.
Seresto is odour-free and has a safety release mechanism to prevent strangulation. It is available in three sizes, Seresto Cat for cats less than 8kgs, Seresto Small Dog for dogs up to 8kgs and Seresto Large Dogs, for dogs over 8kg.
For further information about Seresto, contact your Bayer territory manager or call 01635 563000.
Boehringer Ingelheim Vetmedica is giving veterinary practices the chance to offer cat owners a free 3ml pack of Metacam to trial treatment in cats with chronic pain.
Boehringer says each free Metacam pack will provide up to seven days' pain relief to an average-sized arthritic cat, and that it comes in an easy-to-administer cat friendly syringe for accurate dosing. The company also points towards a study which demonstrates that Metacam is highly palatable in 95% of cats1.
To qualify for the offer, veterinary surgeons have to fill in a redemption form logging five new cases. The offer is limited to 25 free bottles per practice. Replacement stock will be sent via your usual veterinary wholesaler. In addition, all completed forms will be entered into a prize draw to win one of six copies of the textbook 'Feline Orthopedics'
According to Boehringer, it is estimated that up to 90% of older cats (over 12 years of age) have radiographic evidence of degenerative joint disease2. However, cats may be more restrained than dogs in the way they react to chronic OA pain, and subtle behaviour changes can be a sign that cats are suffering from chronic pain3.
For further information on Metacam and the 3ml trial pack offer, contact your local Boehringer Ingelheim Vetmedica territory manager or telephone 01344 746959.
References
Novartis Animal Health has launched a new website providing product information, news, up to date advice and insights into key issues facing the farming industry.
Nikki Crossley, Associate Brand Manager at Novartis Animal Health, said: "This new site is set to offer our customers a fantastic new resource and learning space as well as an opportunity to interact with us as a company. We aim to provide a service which is not typically associated with animal health companies and bring key elements of the industry closer together."
Farmers, vets and SQPs are invited to register at: http://www.farmanimalhealth.co.uk/.
Pete Wedderburn MRCVS is reporting on the latest veterinary developments in the USA, with a daily blog from the Western Veterinary Conference in Las Vegas.
You can read / subscribe to Pete's engaging blog here.
Petplan has revealed the top 10 most claimed for health conditions in cats and dogs for 2011.
They were:
Husky, a rather aptly named refrigeration company, has announced it is to launch a veterinary vaccine fridge.
According to the company, the new fridge is a specially adapted version of its SS1 model, one of the most popular refridgerators for caterers because of its performance, reliability and durability.
The new unit is designed to ensure the safe storage of a wide range of vaccines at 2º - 8º degrees Celsius. The unit also incorporates an audible door open alarm, failed temperature alarm, and a fail-safe secondary back-up digital display thermometer as an added safeguard.The vaccine refrigerator door includes security lock as standard, and the refrigerant used in manufacture is R600, a highly efficient hydrocarbon refrigerant coolant - CFC-free and a natural non-greenhouse gas.
Geoff Thomasson, Chief Executive of the Husky team of companies said: "The SS1 has long been a winner with the hospitality trade and we believe we will enjoy similar success with this medical version. The potential market is enormous."
For more information, ring 01455 555340 or email: info@husky-global.com
VetSurgeon.org member Aubrey Kumm MRCVS, a Joint Partner at Companion Care in Harlow, has become one of the first vets based in the UK to gain the GPCert(Endo) from the ESVPS. He joins a group of just 11 vets who currently hold this certificate in Europe.
Aubrey said: "Although there are over 50 veterinary surgeries offering specialist endoscopic surgery in the UK I wanted to ensure I was as well versed as possible in the latest developments of this method of surgery and the ESVPS certificate offered a comprehensive course, the benefits of which I am now able to pass on to clients."
Aubrey's qualification involved a year of study and several examinable components including case studies and a written exam.
The practice has invested around £60,000 in a Force Triad and two laprascopic cameras, along with various operating scopes, a broncoscope,and other associated equipment.
Aubrey added: "As a practice we are now able to offer less invasive surgery to our clients and their pets and we no longer have to ask clients to travel to distant referral centres."
Kruuse has announced that it has become the exclusive distributor for VideoMed GmbH and its range of veterinary endoscopes and documentation systems.
VideoMed produces a range of equine and small animal endoscopes, gastroscopes and laryngoscopes that multifunction with a flexible documentation console. This provides a mobile capability to file, frame and forward digital and dicom images for review and referral diagnosis.
According to Kruuse, VideoMed products are synonymous with the very highest quality of design, function and reliability that have been developed through years of close working relationship with veterinary professionals. An after care and repair service is also provided by the company for its own and a range of other scopes.
Kruuse says the Overground scope gives a mobile, high resolution, recordable image that clearly determines functional and morphological abnormalities of the larynx, pharynx and upper respiratory system (see image right).
Andrew Groom, Managing Director, Kruuse UK Ltd., said: "This exciting agreement will further enhance our equine and small animal presence within the veterinary industry to bring even more leading edge technology to our customers."
For more information, visit www.kruuse.com and http://www.videomed-gmbh.de/
Picture courtesy of:Neil Townsend MSc BVSc Cert ES (Soft Tissue) DipECVS MRCVSClinician in Equine Soft Tissue SurgeryPhilip Leverhulme Equine Hospital
Pfizer's Vet Support+ has launched the Practice Management Academy, which offers online training in the key management disciplines required to run a successful veterinary business.
There are twelve courses which cover four key areas of management: financial operations, staff management, client relations and marketing. Participants can choose to study individual courses, a specific area of management, or enrol in the full Practice Management Academy.
The courses are four weeks in length and contribute up to ten hours of CPD learning through a mix of interactive activities, case studies, questions and a student learning forum.
Each course is also allocated a Pfizer Business Consultant to work as an online expert tutor, posing questions and stimulating forum discussion amongst the students.
Pfizer says that the significant cost saving e-learning represents over external CPD is making the Academy a popular choice for all members of the practice team, especially those who may be taking on new management responsibilities or those looking for a refresher. According to the company, one large vet group has already taken twenty places on each of the courses to improve the practice management skills across its extensive team.
Ned Flaxman, Director Business Innovation said: "Using an E-Learning platform is a well-trodden path, ideal for busy individuals wishing to improve or gain new practice management skills without leaving the surgery, or sofa. However, unlike some e-learning which can leave the participant feeling like they are gaining theoretical know-how only, and working in somewhat of a silo, our Academy offers an 'online campus'. This provides a flexible, convenient and supportive training environment for shared theory and practical learning with other colleagues from the veterinary profession under the guidance of e-tutors and experts."
For further details visit http://www.vetsupportplus.co.uk/
Vets Now has won the 'Social Entrepreneur of the Year' award in the Scottish Business Awards for Pet Blood Bank UK.
The charity was initiated by a Vets Now employee, Wendy Barnett, following a change in legislation which created the opportunity to establish a pet equivalent of the human national blood transfusion service. After a trial through Vets Now, Pet Blood Bank UK was set up in 2007 as an independent charity, with a loan and ongoing fundraising support from Vets Now.
Pet Blood Bank UK collects blood from donor dogs, processes it and supplies it to the veterinary profession to use in cases such as traumatic injuries or where major surgery is required. Last year 164 specially organised dog donor sessions were held where owners are encouraged to bring along their dog to 'donate a pint'. Each donation has the potential to save up to four lives. Nearly 9,000 units of blood have been collected in the past five years.
The charity, which has an education and animal welfare remit, charges veterinary practices just the costs incurred in collecting, processing and storing the blood. As well as providing blood, the Pet Blood Bank UK team are experts in transfusion medicine and receive numerous calls through their advice service. Regular lectures, educational talks to the profession and guidance is given to enquiries from all over the world on how to set up a blood bank.
Wendy Barnett, who is now Head of Clinical and Professional Services at Pet Blood Bank UK, said: "At the heart of our charity is a real desire to ensure that should a dog need blood there is a supply available and I'm delighted that our work, and the support of our many doggy donors and their owners, has been recognised through this award.
"Literally thousands of dog lives have been saved as a result of the service and this has been a real collective effort with Vet Supervisor Jenny Walton and the team here contributing to our success. However, we can't rest on our laurels. Demand from vets has been such that we've had to increase our donor sessions considerably. Like humans, there is a less common dog blood type and we desperately need dogs with negative blood type - such as Greyhounds, Weimaraners, Flat Coat Retrievers, Airedales, Boxers, Dobermans and German Shepherd Dogs to donate at our sessions."
Richard Dixon, founder of Vets Now, said: "Wendy was instrumental in setting up the charity and through her vision and leadership donation sessions have grown from one to three a week, with a 38% increase in donations year on year. We are proud of what Wendy has achieved and the role that the charity now plays in providing much needed blood and guidance to veterinary practices the length and breadth of the UK."
The RCVS Disciplinary Committee has dismissed a case against an Essex-based veterinary surgeon, having found him not guilty of charges relating to the measurement of horses and ponies.
At the ten-day hearing, Marc Auerbach of Oak Equine Veterinary Surgery, Ongar, answered charges relating to measuring the height of 29 horses/ponies presented for measurement by two agents in early 2009. Dr Auerbach had undertaken these measurements as an Official Measurer (OM) for the Joint Measuring Board (JMB), which provides a system for independently measuring and certifying the size of competition horses/ponies. An animal's financial value relates to its size, with larger animals being more likely to win in their competitive class.
The case centred on the expected accuracy of such measurements, whether Dr Auerbach was dishonest in colluding with the agents, or whether there had been signs of malpractice which a reasonably competent vet acting as an OM ought to detect.
From evidence submitted, the Committee determined a margin for measurement accuracy, and consequently dismissed from its consideration ten animals where the difference between the initial measurement and the re-measurement was 3 cm or less. However, the College submitted that the average difference was so great that, either, Dr Auerbach had failed to take sufficient steps to ensure that the correct measurements were recorded, or else he had been dishonest. Dr Auerbach's Counsel accepted the inference that presenting agents were dishonest, but denied that Dr Auerbach was dishonest or had failed to pick up signs of malpractice on the part of the agents.
The Committee was of the view that there may be unscrupulous presenters capable of materially interfering with the height of horses. While it was unable to determine with certainty the extent to which it could be done, the Committee formed the view that unscrupulous interference (together with intrinsic variables) could have caused the differences between measurement and re-measurement in the 19 horses.
The Committee noted there was no evidence of improper payments being received by anyone. It also accepted evidence that Dr Auerbach was not a dishonest man, taking into account his record of 23 years of honesty and excellence in the profession, unchallenged character references and the lack of any credible motive for him to act dishonestly.
Next, the Committee considered whether there had been signs of preparation malpractice which ought to have been picked up by any reasonably competent veterinary surgeon acting as an OM. The College submitted that Dr Auerbach had failed to take several steps including the amount of time and attention given to the animals he measured, and whether they might be drugged or sedated.
The Committee concluded from the evidence, including scientific papers, that mildly sedated animals may not be distinguishable from properly prepared animals; well-behaved horses were not an indication that something was amiss. The Committee accepted that Dr Auerbach took around 15-20 minutes to measure each of the horses presented on 9 January; and, in the absence of guidance from the JMB, it could not conclude this was rushed or unreasonable. Consequently, the Committee was unable to be satisfied, so that it was sure, that the allegation of failure to take sufficient steps to ensure the recording of correct measurements was proved.
"Accordingly, the decision of the Committee is that the facts set out in the Charge in relation to all the horses and ponies listed have not been proved to the necessary standard of proof," said Prof Peter Lees, speaking on behalf of the Committee as he directed the charges be dismissed.
Boehringer Ingelheim Vetmedica has launched Benefortin (benazepril hydrochloride), an ACE inhibitor licensed for the treatment of congestive heart failure (CHF) in dogs. It is also licensed for the treatment of chronic renal insufficiency (CRI) in cats.
Benefortin uses novel micro-cap technology to mask the taste of the bitter molecule. According to Boehringer, this ensures that Benefortin tastes good1, even if it is bitten, crunched or chewed. The company says taste tests demonstrated 100% palatability in dogs and 92% palatability in cats in home settings1.
Benefortin is available in 5mg and 20mg tablets for dogs and 2.5mg tablets for cats and dogs.
Jemima Scott, Boehringer Ingelheim brand manager said: "The addition of Benefortin to our cardiology portfolio now enables us to provide veterinary practices with two of the cornerstones of canine CHF treatment, and the palatability of Benefortin makes it an excellent choice for vets needing to prescribe an ACE inhibitor."
To support the launch of Benefortin, Boehringer is offering veterinary practices the opportunity to win one of three Bosch microwave ovens in a prize draw by answering three multiple choice questions on the ACE inhibitor.
For further information on Benefortin, contact your local Boehringer Ingelheim Vetmedica territory manager or telephone 01344 746959.
A new study has revealed that owners of obese dogs which successfully lose weight notice significant improvement in their dogs' quality of life too.
The study, published in The Veterinary Journal and available online here, was conducted by scientists from the Royal Canin Weight Management Clinic at Liverpool University in conjunction with the Pain and Welfare Group at the University of Glasgow and the Waltham Centre for Pet Nutrition. It looked at fifty obese dogs that had been referred to Royal Canin's clinic.
The results showed that quality of life improved in the dogs that successfully lost weight, demonstrated by increased vitality scores and decreased scores for emotional disturbance and pain. The improvements in vitality score were greater the more body fat the dogs lost. The research also found that the dogs that failed to complete their weight loss programme had lower vitality and higher emotional disturbance scores than those successfully losing weight.
Dr. Alex German, Royal Canin senior lecturer at the University of Liverpool and lead author of the study, said: "Obesity is a risk for many dogs, affecting not only their health, but also their quality of life. The results indicate that, for obese dogs, weight loss can be important for staying both healthy and happy."
Owners completed a questionnaire to determine the health-related quality of life of their dog prior to weight loss, with a follow-up questionnaire for the owners of the thirty dogs that successfully completed the weight loss programme to reach target weight. The completed questionnaire responses were converted into scores corresponding to a range of factors, including vitality, emotional disturbance and pain.
The BSAVA has released a statement in support of the television programme Pedigree Dogs Exposed - three years on, made by Jemima Harrison. The programme was broadcast earlier this week on BBC4 as a follow up to a documentary which was first shown in 2008.
BSAVA President Andrew Ash said: "Jemima Harrison has highlighted an important issue. It is essential that veterinary surgeons, dog breeders and the general public no longer accept that breeding for extremes of conformation or knowingly from animals with inherited disease is an acceptable practice. The programme highlighted two main areas of concern, firstly the small genetic pool that exists in many breeds and secondly continued breeding for extremes of body shape. Both these areas must be addressed urgently. A civilised nation must agree that it is not acceptable to breed dogs that cannot function as dogs."
He went on to say that: "BSAVA supports the health schemes that are now available to owners as steps in the right direction. However it is difficult to believe that health schemes are going to be sufficient in themselves to tackle these problems rapidly and effectively. It is particularly perverse to be promoting health schemes and yet continuing to allow the registration and showing of progeny with Coefficients of Inbreeding as high as 47.5% or where the animal concerned is known to have failed a screening test (significant in that breed)."
Vice President Mark Johnson said: "We are supportive of the changes that the Kennel Club has made so far, and applaud them in allowing the introduction of new genes into certain breeds as demonstrated by the registration of the LUA Dalmatian. I support the introduction of the "Mate Select" scheme (link) but believe that the Kennel Club should adopt the Advisory Council on Welfare in Dog Breeding recommendation and not register puppies with a coefficient of breeding (over 5 generations) greater than 12.5%."
The BSAVA says it supports the BVA in its call for a radical review of all breed standards to ensure that they actively protect the health and welfare of the dog. However it is important to remember that inherited disease is not just a problem of purebred dogs and BSAVA supports the introduction of legislation that seeks to improve the health and welfare of all dogs.
Boehringer Ingelheim is offering a free stainless steel bolus applicators, worth £42.60/€ 59.39 (plus VAT), with the first 1,000 Bovikalc multipacks sold after 1st March in the UK and Eire.
According to the company, milk fever is recognised as the most common mineral deficiency affecting transition cows; one that has a significant impact on the overall health of affected animals, even those showing no outward symptoms. This offer aims to help combat this costly but preventable disease.
The offer is open to farmers, vets and suppliers of Bovikalc and one free applicator will be provided for each Bovikalc multipack - 6 x 4 boluses.
Farmers are required to apply for the free applicators through their veterinary surgeon or Bovikalc supplier.
For further information, including the terms and conditions of the offer, visit www.bovikalc.co.uk. Alternatively, contact your regional cattle specialist or call Boehringer on 01344 746959.
Over 100 students from Nottingham Vet Society will attempt the 3 Peaks Challenge by climbing Ben Nevis, Scafell Pike and Snowdon in under 24 hours on 10 March.
The funds raised will be split between VBF, the charity that supports veterinary professionals, and Medical Detection Dogs.
Online donations can be made at http://goo.gl/IkodW.
Lydia Brown, VBF President, said: "We are so grateful to the students involved who organized this off their own backs even though they don't have much free time. It augurs well for the future of the profession that they want to support their colleagues. I do hope they all make it back to Nottingham safely and I look forward to seeing the pictures on facebook.com/VetlifeVBF! "
Tom McKay, one of the students who organized the challenge, said: "We have really enjoyed the training and are reasonably optimistic we will make it back for our Easter placements!"
Companion Care Vets has been named as one of The Sunday Times 100 Best Companies To Work For, the first veterinary organisation to receive the accolade.
Companion Care, which has 90 surgeries across the UK (the majority within Pets at Home stores) launched its joint venture partner model in 2001. The group received a "first class" one-star status from The Sunday Times, and was ranked at number 69 overall, a position determined by employee views, staff policies, processes and services.
Best Companies Accreditation is based around employee engagement and listed companies are noted for "excelling in every area throughout the workplace." Particularly recognised is an organisation's commitment to its most important assets - its workforce.
Jane Balmain, Managing Director of Companion Care Vets said: "We value every member of our team who have all worked tirelessly over the past 11 years to help our expansion into the market leader we are today. Without the commitment and expertise of every person within the organisation this would not have been possible and for us to receive this recognition, and on our first try, is outstanding."
Jane added: "To be the first veterinary organisation to receive Best Companies Accreditation is an honour and we will strive to continue to provide an exceptional working environment for our teams."
As part of the survey process 79% of Companion Care Vets' employees said their jobs are good for personal growth, 76% felt their jobs were secure and a fantastic 81% said colleagues are committed to taking care of each other.
With 109 Joint Veterinary Partners and a further 867 employees in the group, Companion Care Vets is one of the largest veterinary employers in the UK. The company plans to have 200 surgeries in place by 2015 which will create a host of career opportunities for vets and veterinary support teams around the UK.
Novartis Animal Health has announced that it is offering regular updates Schmallenberg virus, including the number and counties of affected farms, on its farm animal health website: www.farmanimalhealth.co.uk.
The new website is a resource for vets, SQPs and farmers and also contains background information on the virus, its symptoms and suggestions for control.
Helen Langham, Brand Manager at Novartis Animal Health, said: "There is still a lot that isn't known about the Schmallenberg virus, so it is essential that those involved in the animal health industry and livestock production are kept informed. Our website provides current information and links to relevant resources to help people stay up to date".
For more information go to www.farmanimalhealth.co.uk/latestdiseaseupdates
The candidates for this year's RCVS Council election have been announced, many of whom will be coming to the VetSurgeon.org forums to lay out their stalls and explain why you should vote for them.
A record number of veterinary surgeons - 14 - are contesting six seats in the RCVS Council election. Veterinary surgeons may each vote for up to six candidates to fill these seats, which fall vacant as elected Council member's terms of office expire at the RCVS Annual General Meeting (6 July). In 2012, five existing Council members are seeking re-election, and nine new candidates are standing.
Of the 42 RCVS Council members, four are appointed by the Privy Council, 14 by the veterinary schools and 24 by direct election; each member serves a four year term. This year's candidates are:
Voting opens from Friday 9 March and all veterinary surgeons eligible to vote should receive their ballot papers shortly. Votes must be received by 5pm on 27 April 2012 and, as in previous years, can be cast online, by post, or by text message